Breast Cancer Imaging Market by Types of Imaging Techniques (Mammography, Breast Ultrasound, and Breast MRI, Image-guided Breast Biopsy, and Others), End-users (Hospitals, Diagnostic Centers, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028
The global breast cancer imaging market size was valued USD 3.6 billion in 2020 and is anticipated to register at a robust CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the improved quality of breast images, patient comfort, and reduced patient dose.
Breast cancer imaging system is a diagnostic tool utilized for locating the site of cancer cells. It provides detailed information such as extent of the disease as well as the structural changes. Cancer imaging systems detect the tumor in the body and its associated complications, which helps in the evaluation of the post therapeutic treatment by specialists.
Breast cancer imaging is also used to evaluate the stages. Mammography, ultrasonography, and breast magnetic resonance imaging (MRI) are three types of imaging systems that are used for detection of breast cancer.
Market Trends, Drivers, Restraints, and Opportunities
- Increasing technological advancements in the field of breast imaging and rising investment from different organizations for breast cancer screening campaigns are projected to boost the market growth.
- Patient is exposed to multiple sets of radiations for therapeutic purposes during breast imaging procedures, which can create challenges for the growth of the market.
- Growing awareness about screening programs is speculated to stimulate the market growth.
- Rising adoption of advanced mammography devices with innovative technologies is estimated to drive the market growth in the coming years.
- Extensive adoption of artificial intelligence (AI) and machine learning (ML) to improve patient quality of life, which is expected to push the market growth.
- Ionizing and non-ionizing imaging technologies help in the early detection and diagnosis of breast cancer. Thus, such imaging technologies can boost the market expansion in the projected timeline.
- High cost of equipment can hamper the market expansion in the coming years.
- The reduced medical staff availability for cancer treatment due to the COVID-19 outbreak can negatively impacting the breast cancer imaging market.
- Increasing R&D investment to develop breast cancer imaging systems that provide better sensitivity to detect smaller carcinomas is estimated to create lucrative opportunities for the market players.
Scope of the Report
The report on the global breast cancer imaging market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
| Attributes | Details |
| Report Title | Breast Cancer Imaging Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
| Base Year | 2020 |
| Historic Data | 2018–2019 |
| Forecast Period | 2021–2028 |
| Segmentation | Types of Imaging Techniques (Mammography, Breast Ultrasound, Breast MRI, Image-guided breast biopsy, and Others), End-users (Hospitals, Diagnostic Centers, and Others) |
| Regional Scope | Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
| Report Coverage | Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
| Key Players Covered in the Report | General Medical Merate S.p.A., Aurora Health Care, CMR Naviscan Corporation, SonoCine, Inc., and Dilon Technologies, Inc |
Breast Cancer Imaging Market Segment Insights
Mammography segment to constitute a large market share
Based on types of imaging techniques, the market is divided into mammography, breast ultrasound, breast MRI, image-guided breast biopsy, and others. The mammography segment is expected to represent a major market share during the forecast period. Rising initiatives taken to increase the awareness about the breast cancer is expected to propel the market growth. Mammography is the standard technique used to screen breast cancer in government and private healthcare hospitals. Government state bodies across the globe are taking initiatives to provide treatment for women between the age 50 and 75, spurring the segment growth.
Hospitals segment to expand a substantial CAGR
In terms of end-users, the market is segmented into hospitals, diagnostic centers, and others. The hospitals segment is anticipated to register a substantial CAGR during the forecast period. Increasing healthcare infrastructure development, higher purchasing power, and availability of well-equipped operating & diagnostic rooms, and better health coverage for healthcare services are expected to proliferate the segment growth.
North America to dominate the market
On the basis of regions, the market is categorized as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to dominate the market during the forecast period. The regional market growth can be attributed to the growing burden of breast cancer coupled with advancement in healthcare infrastructure and rising healthcare expenditure.
Segments
Segments Covered in the Report
The global breast cancer imaging market has been segmented on the basis of
Types of Imaging Techniques
- Mammography
- Breast Ultrasound
- Breast MRI
- Image-Guided Breast Biopsy
- Others
End-users
- Hospitals
- Diagnostic Centers
- Others
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- General Medical Merate S.p.A.
- Aurora Health Care
- CMR Naviscan Corporation
- SonoCine, Inc.
- Dilon Technologies, Inc
Competitive Landscape
Key players competing in the breast cancer imaging market include General Medical Merate S.p.A., Aurora Health Care, CMR Naviscan Corporation, SonoCine, Inc., and Dilon Technologies, Inc.
2. Assumptions and Acronyms Used
3. Research Methodology
4. Breast Cancer Imaging Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Breast Cancer Imaging Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Breast Cancer Imaging Market - Supply Chain
4.5. Global Breast Cancer Imaging Market Forecast
4.5.1. Breast Cancer Imaging Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Breast Cancer Imaging Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Breast Cancer Imaging Market Absolute $ Opportunity
5. Global Breast Cancer Imaging Market Analysis and Forecast by End Users
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by End Users
5.2.2. Y-o-Y Growth Projections by End Users
5.3. Breast Cancer Imaging Market Size and Volume Forecast by End Users
5.3.1. Hospitals
5.3.2. Diagnostic Centers
5.3.3. Others
5.4. Absolute $ Opportunity Assessment by End Users
5.5. Market Attractiveness/Growth Potential Analysis by End Users
6. Global Breast Cancer Imaging Market Analysis and Forecast by Region
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Region
6.2.2. Y-o-Y Growth Projections by Region
6.3. Breast Cancer Imaging Market Size and Volume Forecast by Region
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa (MEA)
6.4. Absolute $ Opportunity Assessment by Region
6.5. Market Attractiveness/Growth Potential Analysis by Region
6.6. Global Breast Cancer Imaging Demand Share Forecast, 2019-2026
7. North America Breast Cancer Imaging Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.2. North America Breast Cancer Imaging Market Size and Volume Forecast by Country
7.2.1. U.S.
7.2.2. Canada
7.3. Absolute $ Opportunity Assessment by Country
7.4. North America Breast Cancer Imaging Market Size and Volume Forecast by End Users
7.4.1. Hospitals
7.4.2. Diagnostic Centers
7.4.3. Others
7.5. Basis Point Share (BPS) Analysis by End Users
7.6. Y-o-Y Growth Projections by End Users
7.7. Market Attractiveness/Growth Potential Analysis
7.7.1. By Country
7.7.2. By Product Type
7.7.3. By Application
7.8. North America Breast Cancer Imaging Demand Share Forecast, 2019-2026
8. Latin America Breast Cancer Imaging Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Latin America Average Pricing Analysis
8.2. Latin America Breast Cancer Imaging Market Size and Volume Forecast by Country
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Absolute $ Opportunity Assessment by Country
8.4. Latin America Breast Cancer Imaging Market Size and Volume Forecast by End Users
8.4.1. Hospitals
8.4.2. Diagnostic Centers
8.4.3. Others
8.5. Basis Point Share (BPS) Analysis by End Users
8.6. Y-o-Y Growth Projections by End Users
8.7. Market Attractiveness/Growth Potential Analysis
8.7.1. By Country
8.7.2. By Product Type
8.7.3. By Application
8.8. Latin America Breast Cancer Imaging Demand Share Forecast, 2019-2026
9. Europe Breast Cancer Imaging Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Europe Average Pricing Analysis
9.2. Europe Breast Cancer Imaging Market Size and Volume Forecast by Country
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. U.K.
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Absolute $ Opportunity Assessment by Country
9.4. Europe Breast Cancer Imaging Market Size and Volume Forecast by End Users
9.4.1. Hospitals
9.4.2. Diagnostic Centers
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by End Users
9.6. Y-o-Y Growth Projections by End Users
9.7. Market Attractiveness/Growth Potential Analysis
9.7.1. By Country
9.7.2. By Product Type
9.7.3. By Application
9.8. Europe Breast Cancer Imaging Demand Share Forecast, 2019-2026
10. Asia Pacific Breast Cancer Imaging Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Asia Pacific Average Pricing Analysis
10.2. Asia Pacific Breast Cancer Imaging Market Size and Volume Forecast by Country
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.2.4. India
10.2.5. Australia
10.2.6. Rest of Asia Pacific (APAC)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Asia Pacific Breast Cancer Imaging Market Size and Volume Forecast by End Users
10.4.1. Hospitals
10.4.2. Diagnostic Centers
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by End Users
10.6. Y-o-Y Growth Projections by End Users
10.7. Market Attractiveness/Growth Potential Analysis
10.7.1. By Country
10.7.2. By Product Type
10.7.3. By Application
10.8. Asia Pacific Breast Cancer Imaging Demand Share Forecast, 2019-2026
11. Middle East & Africa Breast Cancer Imaging Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Middle East & Africa Average Pricing Analysis
11.2. Middle East & Africa Breast Cancer Imaging Market Size and Volume Forecast by Country
11.2.1. Saudi Arabia
11.2.2. South Africa
11.2.3. UAE
11.2.4. Rest of Middle East & Africa (MEA)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Middle East & Africa Breast Cancer Imaging Market Size and Volume Forecast by End Users
11.4.1. Hospitals
11.4.2. Diagnostic Centers
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by End Users
11.6. Y-o-Y Growth Projections by End Users
11.7. Market Attractiveness/Growth Potential Analysis
11.7.1. By Country
11.7.2. By Product Type
11.7.3. By Application
11.8. Middle East & Africa Breast Cancer Imaging Demand Share Forecast, 2019-2026
12. Competition Landscape
12.1. Global Breast Cancer Imaging Market: Market Share Analysis
12.2. Breast Cancer Imaging Distributors and Customers
12.3. Breast Cancer Imaging Market: Competitive Dashboard
12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
12.4.1. General Medical Merate S.p.A.
12.4.2. Aurora Health Care
12.4.3. CMR Naviscan Corporation
12.4.4. SonoCine, Inc.
12.4.5. Dilon Technologies, Inc
Segments Covered in the Report
The global breast cancer imaging market has been segmented on the basis of
Types of Imaging Techniques
- Mammography
- Breast Ultrasound
- Breast MRI
- Image-Guided Breast Biopsy
- Others
End-users
- Hospitals
- Diagnostic Centers
- Others
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- General Medical Merate S.p.A.
- Aurora Health Care
- CMR Naviscan Corporation
- SonoCine, Inc.
- Dilon Technologies, Inc
Key players competing in the breast cancer imaging market include General Medical Merate S.p.A., Aurora Health Care, CMR Naviscan Corporation, SonoCine, Inc., and Dilon Technologies, Inc.
Our Clients
Related Reports
Some other reports from this category!
